Search Results

Resolving a Double Standard for Risk Management of Thalidomide: An Evaluation of Two Different Risk Management Programmes in Japan

Authors: Ooba, Nobuhiro; Sato, Tsugumichi; Watanabe, Hikaru; Kubota, Kiyoshi

Source: Drug Safety, Volume 33, Number 1, 1 January 2010 , pp. 35-45(11)

Publisher: Adis International

Effects of Native Human Leukocyte Interferon-α and Recombinant Human Interferon-α on P3-X63-Ag8.653 Mouse Myeloma Cell Growth

Authors: Plesničar, A.; Vidmar, G.; Štabuc, B.; Kores Plesničar, B.

Source: The Journal of International Medical Research, Volume 37, Number 5, September 2009 , pp. 1570-1576(7)

Publisher: Field House Publishing

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Authors: Brown, H. K.; Holen, I.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 807-823(17)

Publisher: Bentham Science Publishers

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Authors: Tassone, P.; Tagliaferri, P.; Rossi, M.; Calimeri, T.; Bulotta, A.; Abbruzzese, A.; Caraglia, M.; Neri, P.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 854-870(17)

Publisher: Bentham Science Publishers

Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib

Authors: Dehesa, L.; Bastida, J.; Limeres-González, M.; Campos-Adsuar, C.; Gómez-Duaso, J.

Source: Clinical & Experimental Dermatology, Volume 34, Number 8, December 2009 , pp. e1031-e1032(1)

Publisher: Blackwell Publishing

The Inhibitor of Growth 1 (ING1) Proteins Suppress Angiogenesis and Differentially Regulate Angiopoietin Expression in Glioblastoma Cells

Authors: Tallen, Gesche; Farhangi, Sonja; Tamannai, Mona; Holtkamp, Nikola; Mangoldt, Dorothea; Shah, Sitar; Suzuki, Keiko; Truss, Matthias; Henze, Guenter; Riabowol, Karl; von Deimling, Andreas

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 18, Numbers 2-3, 2009 , pp. 95-105(11)

Publisher: Cognizant Communication Corporation

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Authors: Oyan, Basak; Koc, Yener; Ozdemir, Evren; Kars, Ayse; Turker, Alev; Tekuzman, Gulten; Kansu, Emin

Source: Clinical Transplantation, Volume 23, Number 6, November/December 2009 , pp. 839-847(9)

Publisher: Blackwell Publishing

Myeloma kidney with isolated tubulointerstitial light chain deposition in a renal allograft

Authors: Balamuthusamy, S.; Hamrahian, M.; Zhang, R.; Batuman, V.

Source: Clinical Transplantation, Volume 23, Number 6, November/December 2009 , pp. 848-852(5)

Publisher: Blackwell Publishing

Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation

Authors: Özdemir, Evren; Bayraktar, Miyase; Sökmensüer, Cenk; Kir, K. Metin; Kansu, Emin

Source: Clinical Transplantation, Volume 23, Number 6, November/December 2009 , pp. 981-984(4)

Publisher: Blackwell Publishing

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Authors: Fruehauf, Stefan; Veldwijk, Marlon Romano; Seeger, Timon; Schubert, Mario; Laufs, Stephanie; Topaly, Julian; Wuchter, Patrick; Dillmann, Falk; Eckstein, Volker; Wenz, Frederik; Goldschmidt, Hartmut; Ho, Anthony Dick; Calandra, Gary

Source: Cytotherapy, Volume 11, Number 8, November 2009 , pp. 992-1001(10)

Publisher: Informa Healthcare

NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 908-908(1)

Publisher: Cold Spring Publishing, LLC

Novel Therapies in the Treatment of Multiple Myeloma

Authors: Laubach, Jacob P.; Mitsiades, Constantine S.; Mahindra, Anuj; Schlossman, Robert L.; Hideshima, Teru; Chauhan, Dharminder; Carreau, Nicole A.; Ghobrial, Irene M.; Raje, Noopur; Munshi, Nikhil C.; Anderson, Kenneth C.; Richardson, Paul G.

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 947-960(14)

Publisher: Cold Spring Publishing, LLC

Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Author: Harousseau, Jean-Luc

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 961-970(10)

Publisher: Cold Spring Publishing, LLC

Supportive Therapies in Multiple Myeloma

Authors: Gleason, Charise; Nooka, Ajay; Lonial, Sagar

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 971-979(9)

Publisher: Cold Spring Publishing, LLC

Lenalidomide in multiple myeloma

Authors: Sirohi, Bhawna; Powles, Ray

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1559-1570(12)

Publisher: Expert Reviews

Peroxisome proliferator-activated receptor γ agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells

Authors: Aouali, Nassera; Palissot, Valérie; El-Khoury, Victoria; Moussay, Etienne; Janji, Bassam; Pierson, Sandrine; Brons, Nicolaas H. C.; Kellner, Laurent; Bosseler, Manon; Van Moer, Kris; Berchem, Guy

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 662-671(10)

Publisher: Blackwell Publishing

In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465

Authors: Negri, Joseph M.; McMillin, Douglas W.; Delmore, Jake; Mitsiades, Nicholas; Hayden, Patrick; Klippel, Steffen; Hideshima, Teru; Chauhan, Dharminder; Munshi, Nikhil C.; Buser, Carolyn A.; Pollard, John; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 672-676(5)

Publisher: Blackwell Publishing

ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells

Authors: Polito, Letizia; Bortolotti, Massimo; Farini, Valentina; Pedrazzi, Manuela; Tazzari, Pier Luigi; Bolognesi, Andrea

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 710-718(9)

Publisher: Blackwell Publishing

Pazopanib: an antiangiogenic drug in perspective

Authors: Castaneda, Carlos A; Gomez, Henry L

Source: Future Oncology, Volume 5, Number 9, November 2009 , pp. 1335-1348(14)

Publisher: Future Medicine